in vitro Semaglutide is selected as the optimal once weekly candidate
I dont think we can extrapolate that from this study, and again, we dont have a good way to predict which patients will have more side effects than others, Azagury said
Emerging reports of lean mass changes and nutrient insufficiencies during pharmacologically induced weight loss [40, 94, 101] highlight the importance of structured monitoring rather than indiscriminate nutrient replacement
Freeze unconstituted vials at -20 C for storage beyond 6 months
Specifically, in the group of patients prescribed semaglutide for weight loss, 6.7% developed NAION compared to just 0.8% of those on other treatments
As users get more sophisticated in how they interact with LLMs and start injecting personas into the prompt, that layering is becoming the norm, not the exception